Nice run today.Many get shake off when the price down I think.Those who know it is so much undervalue already load a lot of ticket when the price down.Long way to go.I personally load 60 k into it.

When supermx price rm5 ,I saw 7.3 in pre open queue.Then Adventa I saw 1.25 in pre open then now fulfill.This morning I saw 8.90 supermx in pre open.I think will go to that price.Good to all of us.

Supermx always last minute goes up.Hope today will be the same.Thanks everyone.

Demand takeover supply

Glove momentum come back when all profit taking finish.May the force be with you.

Klse goes green

Shark come back

Selling Force I think almost over.

SUPERMAN Bapak Come in sapu liao.

You see the shark come in liao.Sapu .Load more let it hit 8.00 today

Buy when people are fearful.Sell when people are greedy.

Let them sell sell sell then only people can buy more.Then tonight DJI when 26000 then tomolo will huat huat liao lo.888888i8i8i888888

No peak limit during this covid19

Up so many,down back little little is acceptable.You will never know the peak of this counter.

Yup 7.72 7.67 i also load.No scare of this counter.888888888888888 Huat ah tomolo Hoseh liao. Wait all profit taking finish thenBig shark will come in.8888888888888

Wait selling force over then lowd more

Will drop abit then go higher.dont worry

Many good factor to drive up the price today.Good luck everyone.TP at least 10.00.Already got hint from SBB.

Dow Jones 25,548.27 +553.16 2.21%
Nasdaq 9,412.36 +72.136 0.77%
Going towards 29000 area.

Oil Plunges After API Reports Large Unexpected Crude Inventory Build.

The American Petroleum Institute (API) estimated on Tuesday a large crude oil inventory build, of 8.731 million barrels for the week ending May 22. Analysts had predicted an inventory draw of 2.50 million barrels. In the previous week, the API estimated a draw in crude oil inventories of 4.8 million barrels. Meanwhile, the EIA’s estimates were for wildly different, with the industry body reporting last week that the inventories had fallen by 5 million barrels. WTI was trading down on Wednesday afternoon prior to the API’s data release,…

USA Stocks set to open higher; Chinese markets fall again

Oil prices are consolidating, as the unrest in Hong Kong and the political rumblings between the U.S. and China prompt a little caution, after a week of sharp gains.Therefore more fund will rush in glove sector.

KUALA LUMPUR (27 Julai): Supermax Corp Bhd mengumumkan pada 22 Mei 2020 bahawa ia telah menyelesaikan pengambilalihan tanah industri seluas 2.02 hektar di Klang Middle Road (Meru) dengan harga RM20 juta.

Pada bulan Mac tahun ini, Supermax menandatangani perjanjian penjualan dengan Nishimen Industries (M) Sdn Bhd melalui anak syarikat milik penuhnya, Maxter Glove Manufacturing Sdn Bhd.

"Pemerolehan ini adalah untuk memperluas kapasiti pembuatan Kumpulan di lokasi strategik berdekatan dengan kilang yang ada di masa depan, yang akan membantu mempermudah kawalan pengurusan dan mendapatkan sinergi dan kecekapan maksimum dari segi operasi dan kawasan tanah yang tersedia."

Tomolo sure gap up 0.500 and continue sailing again.We are sailing we are sailing~~~~~

Speakup me too,I sold all at 6.20.Thought can buy back cheaper.Then before closing tekan buy at 6.95.Hahhahhaa.Still long way to go.This time no see 13.00 no sell.The price at least same with Top glove base on calculations.

Joyvest and other.If I follow you,I wont make so much money today.You bitch.Go back Holland lah.

Vaccines news to Glove counter no effect already,since all people realized it will take long time process.No effect at all.

Top glove S$ 4.42 in Singapore stock exchange rose 0.53(13.62%)on Tuesday.Riverstone Singapore also up 0.26.Think Wednesday Supermx no problem at all!!!

https://www.google.com/search?sxsrf=ALeKk03PW9BLNRpwUQ2wB8CKYRwdT8Ezuw:1590516249376&q=SGX:+BVA&stick=H4sIAAAAAAAAAONgecRowS3w8sc9YSn9SWtOXmPU5OIKzsgvd80rySypFJLmYoOyBKX4uXj10_UNDVNSKkviCywseRaxcgS7R1gpOIU5AgCxLMyUSAAAAA&sa=X&ved=2ahUKEwiHvrbgjtLpAhUFOSsKHeeOBqoQ3N8BMAN6BAgJEAM&sxsrf=ALeKk03PW9BLNRpwUQ2wB8CKYRwdT8Ezuw:1590516249376&biw=412&bih=756&dpr=3.5

How if people follow your opinion and sell,and then the price shoot up to 9.00 dollar?People lost the chance to make money,you happy issit mada fatker. Black heart species.

No need to scare people to sell.Bad hearted people you all.You all want to buy in issit?If the price drop,many people will lost money,you want that issit,shrimp brain.You are not on the boat but you want the boat sink and all die.You think lah ,how bad hearted you are.Mada father.

Vaccines? Long way to go.Those red eye people don't spread fake news about vaccine.Wait next year for vaccine.

"U.S. officials and scientists are hopeful a vaccine to prevent Covid-19 will be ready in the first half of 2021 — 12 to 18 months since Chinese scientists first identified the coronavirus and mapped its genetic sequence.

It’s a record-breaking time frame for a process that normally takes about a decade for an effective and safe vaccine. The fastest-ever vaccine development, mumps, took more than four years and was licensed in 1967. A lot has changed since then that gives scientists reasonable hope a Covid-19 vaccine could be available early next year. "

Why Creating a Covid-19 Vaccine Is Taking So Long
Developing a vaccine that’s both effective and safe is grueling, methodical work. And once we have one, we’ll need many, many doses too.

The race is on for a Covid-19 vaccine, but the pace is less hare and more tortoise. And necessarily so: Developing a vaccine that’s both effective and safe is grueling, methodical work.

“When experts optimistically say that they expect a Covid-19 vaccine by the end of 2020, they’re talking about an emergency use authorized vaccine, not a fully-approved one,” says Dr. Seema Yasmin, director of the Stanford Health Communication Initiative.

No one can say for sure when a Covid-19 vaccine might arrive, because vaccine development is broken into several stages, each with a highly variable timeline. “But here’s a comparison,” Yasmin says. “The fastest vaccine we previously developed was for mumps, and that took four years to develop. And typically it takes 10 to 15 years to develop a vaccine. So 12 to 18 months would be record-breaking.”


Now, about those stages. The first is the exploratory phase, in which drug companies tinker with different approaches. With Covid-19, for instance, some drugmakers are trying to develop a nucleotide-based vaccine, which uses the virus’s genetic code instead of its proteins. Typically, the exploratory phase could take two to four years, though new technologies are speeding up the progress. Also, this novel coronavirus is similar to the first SARS virus, so that may give researchers a head start.

Got a coronavirus-related news tip? Send it to us at covidtips@wired.com.

Next comes the preclinical stage, in which a vaccine candidate is tested in cell cultures and animals to see if it triggers an immune response. “If there’s no immune response or the vaccine is causing harm to cells, then it’s back to square one, the exploratory stage,” says Yasmin. “The reality is there’s no way to speed up this stage, and it will probably take at least a year.”

But if all goes well, the candidate heads to clinical trials. The experimental vaccine is given to a small group of people, then a bigger group, then an even bigger group, typically in an outbreak area. This series of tests can take years to complete. Some bioethicists have recently proposed that the Covid-19 pandemic is so serious that so-called “challenge trials” should be considered to accelerate the process. In a challenge trial, researchers would intentionally infect the people they vaccinate in a controlled environment to see if the drug is effective. No such studies have been authorized yet.


The next stage is regulatory review, in which the manufacturer submits an application for a license to produce the vaccine. In the US, this typically takes 10 months and is authorized through the Food and Drug Administration, though it’s virtually a given that regulators will speed up the approval of a Covid-19 vaccine.

But we aren’t done yet. Scaling up production—for instance, building manufacturing facilities—can take years and hundreds of millions of dollars. The production of any Covid-19 vaccine will of course be fast-tracked, but drugmakers will still need to produce enough materials to vaccinate billions of people.

To learn more about the race for a Covid-19 vaccine, check out our video with Yasmin above.

Fck you Geco.Today will panic buying since tp raise to 7.00.if you want to buy cheaper then wait patiently,don't spread false new.Today will gap up then rally to 6.50 at least.

Retain Add, with a higher TP of RM7.00 We raise our FY20-22F EPS by 8.1-10.6% to account for: i) lower tax rate, and ii) higher ASPs (with more OBM sales contribution). Accordingly, our TP is raised to RM7.00, still based on 27x CY21 P/E, in line with +2 s.d. of its 5-year mean. We view SUCB as a key beneficiary of the strong glove demand from Covid-19, on top of its distribution business, which garners better margins in these times. It continues to be a laggard play, trading at a 45% discount to the Malaysian glove sector’s average CY21F P/E of 35x, while it has the highest 3-year EPS CAGR of 21.2% (vs. average of 15.6%).

Don't worry speak up.This counter is unstoppable!!5.38 I load in also.Nothing to scare for this counter.

Tomolo gap up some more

When will genting qr result out?

KUALA LUMPUR (July 13): Healthcare stocks have skyrocketed. The medical stock index soared 120.16 points or 7.5% on Wednesday to 1722.81. The "four kings" of the glove stocks rose again today, ranking among the top in the ascending list.

The winner of the list is Hitejia (HARTA, 5168, Main Board Health Stock), which surged 17.63% or RM1.33 to RM8.86 throughout the day. Top gloves (TOPGLOV, 7113, motherboard health care stocks) surged 16.52% or RM1.33 throughout the day to RM9.31, taking the runner-up position. The third place is the high-yield products (KOSSAN, 7153, Main Board Health Stocks), which rose 13.81% or 0.87 cents to RM7.17. Super Palm (SUPERMX, 7106, Main Board Health Stocks) rose 4.96% or 17 sen throughout the day to RM 3.60, ranking 25th on the rise.

Other than that. Gloves equipment stocks Heli Technology (HLt, 0188, GEM) and its warrants rose sharply, Heli Technology-WA rose 7 sen or 33% to 28 sen, with a turnover of 50.593 million shares; Heli Technology started 11.5 sen or 30.26% to 49.5 sen, with a turnover of 32.11 million shares. Mother shares and warrants ranked No. 3 and No. 1 on the Hot List respectively.

Maybank investment bank analysts said that the orders received by top gloves have been accumulated until April next year, and its delivery period has been further extended from 5 months to 10 months later. Prior to the outbreak of new coronary pneumonia, the glove delivery period was only one and a half months.

"Other glove companies have also fully sold their production capacity in the next six months to one year. For example, the orders for high-yield products are full this year."

At the same time, the average selling price of glove products has increased in March, and analysts expect the current average selling price to be maintained until the first quarter of next year.

Top net profit is expected to triple

Analysts predict that the top gloves' third quarter (as of May 31) net profit soared 2.9 times and 90% year-on-year and 90%, respectively, because sales are expected to rise 14% and 15% year-on-year and quarterly, and Earnings before interest, tax, depreciation and amortization (EBITDA) will increase from 17% in the second quarter to 22%. The company expects to announce its third quarter results on June 18.

On the other side, analysts at Industrial Bank said that after the outbreak, orders for gloves from China and the Asian region have increased since February. After the epidemic spread, orders from European and American countries rose sharply in March.

The delivery period of Supermax products has been extended to 8 months, much longer than the normal period of 2 to 2.5 months.

"The good news is that with the completion of the new plant at Block 12 in January, Supermax ’s annual production capacity increased by 10%. However, affected by the MCO, the new plant at Block 12 failed to meet the schedule in July. It is estimated that it will be put into operation in the last quarter when it is completed. By then, the annual production capacity will expand by another 9%. "

In addition, the analyst reminded that Supermax has an advantage that more than half of its products are manufactured under its own brand (OBM), and its average selling price is expected to increase by 5% to 15% in fiscal year 2020-2022, which is higher than The 3% to 5% increase of other peers also means that the company can strive for a higher profit margin.

In conclusion, analysts are optimistic about Supermax's upcoming third quarter results (as of March 31) in the next three weeks and will increase earnings forecasts for the fiscal year 2020 to 2020 by 25% to 86%.

It is big shark accumulating push up the price then throw all suddenly.Screw them,frightening me.hahaha

Wtf,luckily I.no.kena shake.i.just went in toilet only.it goes 3.10.Hahaha.

Like what I said,They want to scare of some intraday player

Chiong Ah!!!!

Sapu!!!!

They want to flush out contra player and some profit taking

Yalah,we need money to spend on mco.Thanks Glove.

Everyday glove counter up.Do you believe that.It is like dreaming.Unbelievable.

Second round sapu stock on air.Third round in the afternoon.

Dang dang dang~~~~~~